Corradini Paolo

Full professor
SSD
MED/15 - BLOOD DISEASES
Competition sector
06/D3 - BLOOD DISEASES, ONCOLOGY AND RHEUMATOLOGY

Contacts

Workplace

Via Venezian, 1
20133 MILANO (MI)

Additional phone numbers
02 23902343
University email address

Teaching

Research

Publications
  • Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study / F. Passamonti, C. Cattaneo, L. Arcaini, R. Bruna, M. Cavo, F. Merli, E. Angelucci, M. Krampera, R. Cairoli, M.G. Della Porta, N. Fracchiolla, M. Ladetto, C. Gambacorti Passerini, M. Salvini, M. Marchetti, R. Lemoli, A. Molteni, A. Busca, A. Cuneo, A. Romano, N. Giuliani, S. Galimberti, A. Corso, A. Morotti, B. Falini, A. Billio, F. Gherlinzoni, G. Visani, M.C. Tisi, A. Tafuri, P. Tosi, F. Lanza, M. Massaia, M. Turrini, F. Ferrara, C. Gurrieri, D. Vallisa, M. Martelli, E. Derenzini, A. Guarini, A. Conconi, A. Cuccaro, L. Cudillo, D. Russo, F. Ciambelli, A.M. Scattolin, M. Luppi, C. Selleri, E. Ortu La Barbera, C. Ferrandina, N. Di Renzo, A. Olivieri, M. Bocchia, M. Gentile, F. Marchesi, P. Musto, A.B. Federici, A. Candoni, A. Venditti, C. Fava, A. Pinto, P. Galieni, L. Rigacci, D. Armiento, F. Pane, M. Oberti, P. Zappasodi, C. Visco, M. Franchi, P.A. Grossi, L. Bertu, G. Corrao, L. Pagano, P. Corradini. - In: THE LANCET. HAEMATOLOGY. - ISSN 2352-3026. - 7:10(2020 Oct), pp. e737-e745.
  • Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk / K. Weisel, A. Spencer, S. Lentzsch, H. Avet-Loiseau, T.M. Mark, I. Spicka, T. Masszi, B. Lauri, M.D. Levin, A. Bosi, V. Hungria, M. Cavo, J.J. Lee, A. Nooka, H. Quach, M. Munder, C. Lee, W. Barreto, P. Corradini, C.K. Min, A.A. Chanan-Khan, N. Horvath, M. Capra, M. Beksac, R. Ovilla, J.C. Jo, H.J. Shin, P. Sonneveld, T. Casneuf, N. DeAngelis, H. Amin, J. Ukropec, R. Kobos, M.V. Mateos. - In: JOURNAL OF HEMATOLOGY & ONCOLOGY. - ISSN 1756-8722. - 13:1(2020 Aug 20), pp. 115.1-115.11.
  • High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG) / S. Salmoiraghi, R. Cavagna, P. Zanghi', C. Pavoni, A. Michelato, K. Buklijas, L. Elidi, T. Intermesoli, F. Lussana, E. Oldani, C. Caprioli, P. Stefanoni, G. Gianfaldoni, E. Audisio, E. Terruzzi, L. De Paoli, E. Borlenghi, I. Cavattoni, D. Mattei, A. Scattolin, M. Tajana, F. Ciceri, E. Todisco, L. Campiotti, P. Corradini, N. Fracchiolla, R. Bassan, A. Rambaldi, O. Spinelli. - In: CANCERS. - ISSN 2072-6694. - 12:8(2020 Aug 11), pp. 2242.1-2242.14.
  • Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase / C. Oltolini, A. Guidetti, M. Ripa, B. Castiglioni, C. Tassan Din, S. Mastaglio, D. Canetti, G. Monti, A. Andolina, C. Molinari, A. Poloniato, A. Mastrangelo, M. Ferrante, M. Lanzillotta, P. Scarpellini, A. Castagna, P. Corradini, F. Ciceri. - In: HEMASPHERE. - ISSN 2572-9241. - 4:4(2020 Aug), pp. e448.1-e448.4.
  • Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma : Three-year Follow-up of CASTOR / M.-. Mateos, P. Sonneveld, V. Hungria, A.K. Nooka, J.A. Estell, W. Barreto, P. Corradini, C.-. Min, E. Medvedova, K. Weisel, C. Chiu, J.M. Schecter, H. Amin, X. Qin, J. Ukropec, R. Kobos, A. Spencer. - In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. - ISSN 2152-2650. - 20:8(2020 Aug), pp. 509-518.